BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28074081)

  • 1. The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris.
    Helseth R; Solheim S; Arnesen H; Seljeflot I; Opstad TB
    Mediators Inflamm; 2016; 2016():2182358. PubMed ID: 28074081
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris.
    Li JS; Zhao XJ; Ma BX; Wang Z
    J Biol Regul Homeost Agents; 2016; 30(3):733-741. PubMed ID: 27655490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings.
    Arslan U; Kocaoğlu I; Balci MM; Gülkan B; Falay MY; Temizhan A
    Coron Artery Dis; 2013 Aug; 24(5):404-11. PubMed ID: 23612365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study.
    Helseth R; Knudsen EC; Eritsland J; Opstad TB; Arnesen H; Andersen GØ; Seljeflot I
    BMC Cardiovasc Disord; 2019 Oct; 19(1):221. PubMed ID: 31615411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI.
    Helseth R; Shetelig C; Andersen GØ; Langseth MS; Limalanathan S; Opstad TB; Arnesen H; Hoffmann P; Eritsland J; Seljeflot I
    Mediators Inflamm; 2019; 2019():7816491. PubMed ID: 31772506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
    Byrne RA; Ndrepepa G; Braun S; Tiroch K; Mehilli J; Schulz S; Schömig A; Kastrati A
    Am J Cardiol; 2010 Nov; 106(9):1212-7. PubMed ID: 21029815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction.
    Stakos DA; Kambas K; Konstantinidis T; Mitroulis I; Apostolidou E; Arelaki S; Tsironidou V; Giatromanolaki A; Skendros P; Konstantinides S; Ritis K
    Eur Heart J; 2015 Jun; 36(22):1405-14. PubMed ID: 25660055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culprit site extracellular DNA and microvascular obstruction in ST-elevation myocardial infarction.
    Mangold A; Ondracek AS; Hofbauer TM; Scherz T; Artner T; Panagiotides N; Beitzke D; Ruzicka G; Nistler S; Wohlschläger-Krenn E; Winker R; Quehenberger P; Traxler-Weidenauer D; Spannbauer A; Gyöngyösi M; Testori C; Lang IM
    Cardiovasc Res; 2022 Jun; 118(8):2006-2017. PubMed ID: 34173822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction.
    Iversen KK; Teisner AS; Teisner B; Kliem A; Thanning P; Grande P; Clemmensen P
    Am J Cardiol; 2008 May; 101(10):1389-94. PubMed ID: 18471447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peak CKMB and cTnT accurately estimates myocardial infarct size after reperfusion.
    Hedström E; Aström-Olsson K; Ohlin H; Frogner F; Carlsson M; Billgren T; Jovinge S; Cain P; Wagner GS; Arheden H
    Scand Cardiovasc J; 2007 Jan; 41(1):44-50. PubMed ID: 17365977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance.
    Di Chiara A; Dall'Armellina E; Badano LP; Meduri S; Pezzutto N; Fioretti PM
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):587-92. PubMed ID: 20588136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty.
    Tzivoni D; Koukoui D; Guetta V; Novack L; Cowing G;
    Am J Cardiol; 2008 Mar; 101(6):753-7. PubMed ID: 18328834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in fractalkine in patients with ST-elevation myocardial infarction.
    Yao K; Zhang S; Lu H; Hong X; Qian J; Sun A; Zou Y; Ge J
    Coron Artery Dis; 2015 Sep; 26(6):516-20. PubMed ID: 26049921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine kinase-MB assessed in patients with acute myocardial infarction correlates with cardiac magnetic resonance infarct size at 6-month follow up.
    Rakowski T; Dziewierz A; Legutko J; Kleczynski P; Brzozowska-Czarnek A; Siudak Z; Urbanik A; Dubiel JS; Dudek D
    Hellenic J Cardiol; 2014; 55(1):4-8. PubMed ID: 24491929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troponin I elevation and cardiac events after percutaneous coronary intervention.
    Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
    Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil extracellular traps (NETs) in patients with STEMI. Association with percutaneous coronary intervention and antithrombotic treatments.
    Ferré-Vallverdú M; Latorre AM; Fuset MP; Sánchez E; Madrid I; Ten F; Vallés J; Santos MT; Bonanad S; Moscardó A
    Thromb Res; 2022 May; 213():78-83. PubMed ID: 35306431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.